08/18/2026
🧬 The Future of Regenerative Medicine Starts With Evidence — Part 3/3
At Prostamerx, research doesn’t stop in the laboratory.
Dr. Mukesh explains how the company combines research, clinical trials, real-world evidence, and collaboration with physicians to continuously learn from clinical experience and improve regenerative therapies.
With a network of more than 200 clinics, the goal is not simply to develop therapies, but to understand how they perform in real-world settings while maintaining rigorous quality and regulatory standards, including FDA and GMP requirements.
Most importantly, science moves forward when patients are informed, engaged, and willing to share their experiences.
🔬 Educated patients. Clinical evidence. Continuous research. Better understanding.
That is how we continue working toward the ultimate goal: learning how to improve patients’ lives — and, ultimately, advancing the field for everyone. FDA MAP
